TipRanks
China Regenerative Medicine International Limited (HK:8158)
:8158
Hong Kong Market
Want to see HK:8158 full AI Analyst Report?

China Regenerative Medicine International Limited (8158) Financial Statements

0 Followers

China Regenerative Medicine International Limited Financial Overview

China Regenerative Medicine International Limited's market cap is currently HK$55.07M. The company's EPS TTM is HK$0.0982; its P/E ratio is 1.93; China Regenerative Medicine International Limited is scheduled to report earnings on August 21, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueHK$ 72.06MHK$ 90.62MHK$ 69.49MHK$ 41.54MHK$ 282.90M
Gross ProfitHK$ 41.92MHK$ 57.65MHK$ 19.42MHK$ 37.62MHK$ 67.73M
Operating IncomeHK$ -1.59MHK$ 18.43MHK$ -109.11MHK$ 12.29MHK$ 58.96M
EBITDAHK$ 8.26MHK$ 29.84MHK$ -95.40MHK$ 14.44MHK$ 65.11M
Net IncomeHK$ 27.52MHK$ 17.75MHK$ -107.70MHK$ 4.55MHK$ 51.83M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 8.17MHK$ 57.45MHK$ 3.33MHK$ 1.85MHK$ 9.93M
Total AssetsHK$ 168.06MHK$ 135.71MHK$ 185.90MHK$ 275.91MHK$ 259.14M
Total DebtHK$ 51.31MHK$ 53.69MHK$ 50.19MHK$ 72.01MHK$ 35.82M
Net DebtHK$ 43.14MHK$ 30.99MHK$ 46.86MHK$ 70.16MHK$ 25.89M
Total LiabilitiesHK$ 114.58MHK$ 110.51MHK$ 174.10MHK$ 172.00MHK$ 147.41M
Stockholders' EquityHK$ 53.47MHK$ 25.20MHK$ 11.79MHK$ 103.92MHK$ 111.73M
Cash Flow
Free Cash FlowHK$ 4.03MHK$ 17.68MHK$ 6.06MHK$ -20.25MHK$ -3.83M
Operating Cash FlowHK$ 4.10MHK$ 18.30MHK$ 6.34MHK$ -17.65MHK$ -3.02M
Investing Cash FlowHK$ -70.00KHK$ -622.00KHK$ -262.00KHK$ -2.59MHK$ 9.27M
Financing Cash FlowHK$ -19.11MHK$ 2.37MHK$ -7.36MHK$ 7.32MHK$ -1.39M
Currency in HKD

China Regenerative Medicine International Limited Earnings and Revenue History

China Regenerative Medicine International Limited Debt to Assets

China Regenerative Medicine International Limited Cash Flow

China Regenerative Medicine International Limited Forecast EPS vs Actual EPS